Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services.
Communication
Continuity of Patient Care
Endocrinologists
Endocrinology
/ organization & administration
Health Services Accessibility
Human Growth Hormone
/ deficiency
Humans
Interdisciplinary Communication
Interprofessional Relations
Pediatricians
Pediatrics
/ organization & administration
Practice Guidelines as Topic
Professional-Patient Relations
Quality of Life
Transition to Adult Care
United States
Adult endocrinologist
Childhood-onset growth hormone deficiency
Growth hormone replacement
Pediatric endocrinologist
Transition of care
Journal
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
ISSN: 1532-2238
Titre abrégé: Growth Horm IGF Res
Pays: Scotland
ID NLM: 9814320
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
29
07
2020
revised:
23
11
2020
accepted:
06
12
2020
pubmed:
21
12
2020
medline:
15
2
2022
entrez:
20
12
2020
Statut:
ppublish
Résumé
Most patients with childhood-onset growth hormone deficiency (CO-GHD) receive treatment with exogenous growth hormone (GH) to facilitate the attainment of their full potential adult height. Recent evidence suggests that continuing GH administration during the transition period between the end of linear growth and full adult maturity is necessary for proper body composition and bone and muscle health, and may also have beneficial effects on metabolic parameters, bone mineral density, and quality of life. The timing of this transition period coincides with the transfer of care from a pediatric to an adult endocrinologist, creating the potential for a care gap as a consequence of losing the patient to follow-up. An advisory board comprising both pediatric and adult endocrinologists was assembled to address current clinical unmet needs and to collaborate on a structured transitional plan for optimal management of patients with CO-GHD. The advisors suggest collaborative, multidisciplinary approaches to ensure continuity of care; ongoing testing and monitoring of GHD status into adulthood; and a clearly structured protocol that includes practical guidance for clinicians to establish best practices for transitioning older adolescents with persistent CO-GHD to adult care.
Identifiants
pubmed: 33341524
pii: S1096-6374(20)30084-8
doi: 10.1016/j.ghir.2020.101375
pii:
doi:
Substances chimiques
Human Growth Hormone
12629-01-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101375Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.